Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28599960

Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors

Author
WOONDONG JEONG1 ; RAPISARDA, Annamaria2 ; KUMMAR, Shivaani1 3 ; SOOK RYUN PARK1 ; KINDERS, Robert J2 ; CHEN, Alice1 ; MELILLO, Giovanni2 ; TURKBEY, Baris3 ; STEINBERG, Seth M3 ; CHOYKE, Peter3 ; DOROSHOW, James H1 3
[1] Division of Cancer Treatment and Diagnosis. National Cancer Institute, Bethesda, MD 20892, United States
[2] Leidos Biomedical Research. Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, United States
[3] Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, United States
Source

Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 2, pp 343-348, 6 p ; ref : 20 ref

CODEN
CCPHDZ
ISSN
0344-5704
Scientific domain
Medical oncology; Pharmacology drugs
Publisher
Springer, Heidelberg
Publication country
Germany
Document type
Article
Language
English
Author keyword
Antiangiogenesis HIF mRNA Pharmacodynamics-driven trials Synthetic locked nucleic acid (LNA) oligodeoxynucleotide
Keyword (fr)
Activité biologique Antiangiogénique Essai clinique Facteur transcription HIF1 Homme Inhibiteur Oligodésoxyribonucléotide Oligonucléotide antisens Produit synthétique RNA messager Résistance traitement Tumeur solide Acide nucléique verrouillé Pharmacodynamie Cancer Tumeur maligne
Keyword (en)
Biological activity Antiangiogenic agent Clinical trial Transcription factor HIF1 Human Inhibitor Oligodeoxyribonucleotide Antisense oligonucleotide Synthetic product Messenger RNA Treatment resistance Solid tumor Locked Nucleic Acid Pharmacodynamics Cancer Malignant tumor
Keyword (es)
Actividad biológica Antiangiogenico Ensayo clínico Factor transcripción HIF1 Hombre Inhibidor Oligodesoxirribonucleótido Oligonucleótido antisentido Producto sintético RNA mensajero Resistencia tratamiento Tumor sólido Ácido nucleic bloqueado Farmacodinámica Cáncer Tumor maligno
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors / 002B04C Multiple tumors. Solid tumors. Tumors in childhood (general aspects)

Discipline
Pharmacological treatments Tumours
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
28599960

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web